| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 720340 | Null | 0.00166185890990728 | 0.27735485 |
| NSC 726718 | 3-(Benzothiazol-6-ylamino)-7-chloro-8-methyl-1,1,-dioxo-4H-1 ,5,2-benzodithiazepin-4-ylideneacetic acid | 0.00166185890990729 | 0.56950885 |
| NSC 727985 | NSC 708781 incorporated in micelles, 0.55% (w/w) of drug | 0.00166185890990729 | 0.43888883 |
| NSC 730460 | 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate | 0.00166185890990729 | 0.60414519 |
| NSC 731155 | 6-(3-Aminopropyl)-5,6-dihydro-5,11-dioxo-3-nitro-11H-indeno[ 1,2-c]isoquinoline Hydrochloride salt | 0.00166185890990729 | 0.39129017 |
| NSC 747292 | Null | 0.00166185890990729 | 0.4481714 |
| NSC 755417 | Null | 0.00166185890990729 | 0.42228443 |
| NSC 324368 | 3,5,9-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide | 0.00166561193816139 | 0.1321165 |
| NSC 335766 | Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- | 0.00166561193816139 | 0.6339943 |
| NSC 617826 | Null | 0.00166561193816139 | 0.51847524 |